427
Participants
Start Date
March 1, 2019
Primary Completion Date
September 10, 2020
Study Completion Date
September 10, 2020
Pilocarpine HCl Ophthalmic Solution
Pilocarpine HCl ophthalmic solution 1.25%, one drop in each eye, once daily, for up to 30 days.
Vehicle
Vehicle, one drop in each eye, once daily, for up to 30 days.
Bucci Laser Vision, Wilkes-Barre
Vision Consultants and Surgeons, Falls Church
Waring Vision Institute, Mt. Pleasant
Clayton Eye Center, Morrow
Bowden Eye Associates, Jacksonville
Mid Florida Eye Center, Mt. Dora
South Florida Vision Center, Fort Lauderdale
Newsom Eye & Laser Center, Sebring
Benjamin Knox Lambright, MD, Crystal River
Eye Center South, Dothan
University Eye Surgeons, Maryville
Total Eye Care, PA, Memphis
Cincinnati Eye Institute, Edgewood
Chu Laser Eye Institute, Bloomington
The Midwest Center for Sight, Des Plaines
Jacksoneye, Lake Villa
Tekwani Vision Center, St Louis
Silverstein Eye Centers, Kansas City
Moyes Eye Center, Kansas City
Heart of America Eyecare, Shawnee Mission
Kannarr Eye Care, Pittsburg
Texas Eye & Laser Ctr, Hurst
Keystone Research ltd. at Texan Eye, Austin
The Cataract and Glaucoma Center, El Paso
Corneal Consultants of Colorado, Littleton
Benjamin Travis Dastrup, MD, Ogden
Walman Eye Center, Sun City
M&M Eye Institute, Prescott
Amel Youssef, OD, Las Vegas
Debry Medical Services PC, Las Vegas
Advanced Vision Care, Los Angeles
Global Research Management, Glendale
North Valley Eye Medical Group, Inc., Mission Hills
Milton M. Hom, OD, FAAO, Azusa
Eye Research Foundation, Newport Beach
Lead Sponsor
Allergan
INDUSTRY